跳至主要内容
临床试验/CTRI/2020/06/026045
CTRI/2020/06/026045尚未招募3 期

Evaluating the immune boosting ability of a homoeopathic therapeutic strategy involving a nosode Tuberculinum 1M, followed by Zincum Metallicum 6C, Chininum Arsenicosum 6C and Calc Phos 6x in asymptomatic novel corona virus disease (Covid-19 illness) vulnerable risk group. - Nil

Father Muller Homoeopathic Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All existing co-morbidities.
  • 2. High risk front line workers

排除标准

  • 1.Those with end stage renal disease and progressive liver dysfunctions
  • 2.Pregnant and lactating females
  • 3.Anyone who has taken HCQS and / or Homoeopathic prophylaxis Ars alb 30 / any other similar medicines for boosting the immunity against Covid-19 illness

研究者

发起方
Father Muller Homoeopathic Medical College

相似试验